This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2011-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2014
Title: The Innovations of Celine Schalk-Hihi: Pioneering Advances in Matrix Metalloproteinases
Introduction: Celine Schalk-Hihi, an innovative inventor based in Phoenixville, PA, has made significant contributions to the field of biochemistry and pharmacology. With a remarkable portfolio of six patents, her work primarily focuses on the development of small-molecule allosteric processing inhibitors, addressing critical challenges associated with matrix metalloproteinases (MMPs).
Latest Patents: Schalk-Hihi's latest inventions revolve around methods of treatment utilizing allosteric processing inhibitors for matrix metalloproteinases. These patents include a crystal structure comprising a complex of the pro form of matrix metalloproteinase (proMMP) and a small-molecule allosteric processing inhibitor designed to inhibit the activation of proMMP. Her research delineates methods for identifying these inhibitors and emphasizes their application in treating diseases linked to improper MMP activity. Specifically, her work on the crystal structure of proMMP9 bound to the small-molecule inhibitor represents a cornerstone in designing and optimizing these crucial compounds.
Career Highlights: Celine Schalk-Hihi's career has been marked by her tenure at Janssen Pharmaceutica NV, where she has collaborated extensively on groundbreaking research. Her patents reflect her dedication to advancing therapeutic strategies and improving patient outcomes through innovative science.
Collaborations: In her professional journey, Schalk-Hihi has partnered with esteemed colleagues including Richard Scott Alexander and Frank A Lewandowski. These collaborations highlight the importance of teamwork in driving pharmaceutical innovation and the development of effective treatments.
Conclusion: Celine Schalk-Hihi stands out as a leading inventor in her field, with her contributions poised to make a lasting impact on the treatment of diseases mediated by matrix metalloproteinase activity. With her ongoing commitment to innovation, she continues to inspire future advancements in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile